In the past decades, the expanding use of prostate-specific membrane antigen (PSMA)
imaging for prostate cancer has led to the incidental detection of a lot of extra-prostatic …

Simple Summary Ionizing radiation therapy is an important component of cancer treatment.
This review provides a summary of the latest advancements, clinical use, and limitations of …

Purpose We developed a theranostic radiopharmaceutical that engages two key cell surface
proteases, fibroblast activation protein alpha (FAP) and prostate-specific membrane antigen …

Background: Previously considered inoperable patients (borderline resectable, locally
advanced, synchronous oligometastatic or metachronous pancreatic adenocarcinoma …

Simple Summary Patients diagnosed with pancreatic cancer have a poor prognosis at time
of diagnosis, with a 5-year survival rate of merely 10%. The only treatment with curative …

Background: Prostate-specific membrane antigen (PSMA) is a type II transmembrane
glycoprotein overexpressed on the surface of tumor cells in most of the patients affected by …

Simple Summary Prostate-specific membrane antigen (PSMA)-targeted PET/CT imaging is
increasingly being used for (re) staging in prostate cancer. Although PSMA suggests …

Positron emission tomography (PET) magnetic resonance (MR) enterography is a novel
hybrid imaging technique that is gaining popularity in the study of complex inflammatory …

Pancreatic Cancer (PC) has a poor prognosis, with a 5-year survival rate of only 9%. Even
after radical surgical procedures, PC patients have poor survival rates, with a high chance of …

Tumor vascular physiology is an important determinant of disease progression as well as
the therapeutic outcome of cancer treatment. Angiogenesis or the lack of it provides crucial …